Who cares about the NVCR Optune pivotal Phase 3 trial results in the high quality peer-reviewed journals. NWBO OS data is valid, and many doctors, scientist and professionals all agree. I see that NVCR stock price is the same as it was in 2019 four years ago with a 0% increase. NWBO stock increased from $0.21 to $0.663 four years ago with a 215% increase. Glad to know many of my friends purchased NWBO four years ago. Looking forward to NWBO approvals and the stock price to increase as well.
Market Data 
Markets 
AI
